AXIM BIOTECHNOLOGIES, INC. Quarterly Operating Income (Loss) in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Axim Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2014 to Q2 2024.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$569K, a 18.4% increase year-over-year.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$2.31M, a 40.2% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$2.75M, a 40.9% increase from 2022.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$4.65M, a 66.7% increase from 2021.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2021 was -$14M, a 182% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.31M -$569K +$128K +18.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$2.44M -$402K +$309K +43.5% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-05-22
Q4 2023 -$2.75M -$754K +$388K +34% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$3.14M -$589K +$729K +55.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$3.87M -$698K +$362K +34.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$4.23M -$711K +$422K +37.3% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-05-22
Q4 2022 -$4.65M -$1.14M +$6.51M +85.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$11.2M -$1.32M +$1.96M +59.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$13.1M -$1.06M +$1.12M +51.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$14.2M -$1.13M -$265K -30.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$14M -$7.65M -$5.35M -233% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$8.63M -$3.28M -$1.98M -152% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-15
Q2 2021 -$6.65M -$2.18M -$1.52M -229% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$5.13M -$868K -$179K -26% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$4.95M -$2.3M -$2.55M -1012% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 -$2.4M -$1.3M -$815K -169% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$1.58M -$663K -$79.4K -13.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$1.5M -$689K +$1.6M +70% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-02
Q4 2019 -$3.11M $252K +$975K Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 -$4.08M -$484K +$452K +48.3% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-27
Q2 2019 -$4.54M -$583K +$758K +56.5% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 -$5.29M -$2.29M -$257K -12.6% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-07-02
Q4 2018 -$5.04M -$723K +$327K +31.2% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 -$5.36M -$936K +$249K +21% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$5.61M -$1.34M -$904K -207% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$4.71M -$2.04M -$1.56M -327% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$3.15M -$1.05M -$280K -36.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-08
Q3 2017 -$2.87M -$1.19M +$371K +23.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.24M -$437K +$54.2K +11% Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-08-17
Q1 2017 -$3.29M -$476K +$466K +49.4% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-18
Q4 2016 -$3.76M -$770K +$5.54M +87.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$9.3M -$1.56M +$136K +8.02% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$9.43M -$491K +$1.07M +68.5% Apr 1, 2016 Jun 30, 2016 10-Q/A 2017-09-14
Q1 2016 -$10.5M -$942K -$453K -92.7% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-09-14
Q4 2015 -$10M -$6.31M Oct 1, 2015 Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 -$1.69M -$1.56M -1222% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-11-30
Q2 2015 -$1.56M -$1.56M Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-25
Q1 2015 -$489K Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-05-26
Q3 2014 -$128K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$162* Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.